BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32114664)

  • 1. Self-reported cognitive decline in Japanese patients with breast cancer treated with endocrine therapy.
    Yamamoto S; Masutani E; Arao H
    Breast Cancer; 2020 Jul; 27(4):670-682. PubMed ID: 32114664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.
    Vega JN; Dumas J; Newhouse PA
    Psychooncology; 2018 Sep; 27(9):2198-2205. PubMed ID: 29904964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis.
    Ferreira AR; Di Meglio A; Pistilli B; Gbenou AS; El-Mouhebb M; Dauchy S; Charles C; Joly F; Everhard S; Lambertini M; Coutant C; Cottu P; Lerebours F; Petit T; Dalenc F; Rouanet P; Arnaud A; Martin A; Berille J; Ganz PA; Partridge AH; Delaloge S; Michiels S; Andre F; Vaz-Luis I
    Ann Oncol; 2019 Nov; 30(11):1784-1795. PubMed ID: 31591636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients.
    Gregorowitsch ML; Ghedri A; Young-Afat DA; Bijlsma R; Baas IO; van Schaik-van de Mheen C; Agterof MJ; Göker E; Ten Bokkel Huinink D; van den Bongard HJGD; Verkooijen HM;
    Breast Cancer Res Treat; 2019 Jun; 175(2):429-441. PubMed ID: 30746636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does adjuvant chemotherapy affect menopausal symptoms, sexual function, and quality of life after breast cancer?
    Marino JL; Saunders CM; Emery LI; Green H; Doherty DA; Hickey M
    Menopause; 2016 Sep; 23(9):1000-8. PubMed ID: 27272225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
    Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
    Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
    Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
    J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
    Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
    Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors.
    Nicol C; Ownsworth T; Cubis L; Nguyen W; Foote M; Pinkham MB
    J Cancer Surviv; 2019 Oct; 13(5):653-662. PubMed ID: 31313128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress.
    Levkovich I; Cohen M; Alon S; Kuchuk I; Nissenbaum B; Evron E; Pollack S; Fried G
    J Geriatr Oncol; 2018 Sep; 9(5):469-475. PubMed ID: 29759914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    Gokal K; Munir F; Ahmed S; Kancherla K; Wallis D
    PLoS One; 2018; 13(11):e0206874. PubMed ID: 30485297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
    Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
    Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy?
    Gandhi C; Butler E; Pesek S; Kwait R; Edmonson D; Raker C; Clark MA; Stuckey A; Gass J
    Am J Clin Oncol; 2019 Jun; 42(6):500-506. PubMed ID: 31094713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
    Bluethmann SM; Alfano CM; Clapp JD; Luta G; Small BJ; Hurria A; Cohen HJ; Sugarman S; B Muss H; Isaacs C; Mandelblatt JS
    Breast Cancer Res Treat; 2017 Oct; 165(3):677-686. PubMed ID: 28653250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
    Lee PE; Tierney MC; Wu W; Pritchard KI; Rochon PA
    Breast Cancer Res Treat; 2016 Aug; 158(3):407-20. PubMed ID: 27432418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy.
    Apple AC; Schroeder MP; Ryals AJ; Wagner LI; Cella D; Shih PA; Reilly J; Penedo FJ; Voss JL; Wang L
    Neuroimage Clin; 2018; 20():110-118. PubMed ID: 30094161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.